Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine

Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated... Clin Pharmacokinet (2018) 57:729–737 https://doi.org/10.1007/s40262-017-0591-8 OR IGINAL RESEARCH ARTIC L E Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine 1,2 1,2,5 3,4 • • • Maxim Kuzin Georgios Schoretsanitis Ekkehard Haen 3,4 6,7 1,2 • • • Benedikt Stegmann Christoph Hiemke Gerhard Gru ¨ nder 1,2,8 Michael Paulzen Published online: 2 September 2017 Springer International Publishing AG 2017 Abstract venlafaxine, O-desmethylvenlafaxine and active moiety Background and Objective An increasing trend in pre- (venlafaxine ? O-desmethylvenlafaxine), as well as dose- scribing proton pump inhibitors (PPIs) inevitably increases adjusted plasma concentrations, were compared using non- the risk of unwanted drug–drug interactions (DDIs). The parametrical tests. aim of this study was to uncover pharmacokinetic inter- Results Daily doses of venlafaxine did not differ between actions between two PPIs—omeprazole and pantopra- groups (p = 0.949). The Mann–Whitney U test showed sig- zole—and venlafaxine. nificantly higher plasma concentrations of active moiety, as Methods A therapeutic drug monitoring database con- well as venlafaxine and O-desmethylvenlafaxine, in both PPI tained plasma concentrations of venlafaxine and its active groups [p = 0.023, p = 0.011, p = 0.026, ?29% active metabolite O-desmethylvenlafaxine. We considered three moiety, ?27% venlafaxine, ?36% http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Pharmacokinetics Springer Journals

Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine

Loading next page...
 
/lp/springer_journal/effects-of-the-proton-pump-inhibitors-omeprazole-and-pantoprazole-on-HIfKxvRLE4
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Medicine & Public Health; Pharmacotherapy; Pharmacology/Toxicology; Internal Medicine
ISSN
0312-5963
eISSN
1179-1926
DOI
10.1007/s40262-017-0591-8
Publisher site
See Article on Publisher Site

Abstract

Clin Pharmacokinet (2018) 57:729–737 https://doi.org/10.1007/s40262-017-0591-8 OR IGINAL RESEARCH ARTIC L E Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine 1,2 1,2,5 3,4 • • • Maxim Kuzin Georgios Schoretsanitis Ekkehard Haen 3,4 6,7 1,2 • • • Benedikt Stegmann Christoph Hiemke Gerhard Gru ¨ nder 1,2,8 Michael Paulzen Published online: 2 September 2017 Springer International Publishing AG 2017 Abstract venlafaxine, O-desmethylvenlafaxine and active moiety Background and Objective An increasing trend in pre- (venlafaxine ? O-desmethylvenlafaxine), as well as dose- scribing proton pump inhibitors (PPIs) inevitably increases adjusted plasma concentrations, were compared using non- the risk of unwanted drug–drug interactions (DDIs). The parametrical tests. aim of this study was to uncover pharmacokinetic inter- Results Daily doses of venlafaxine did not differ between actions between two PPIs—omeprazole and pantopra- groups (p = 0.949). The Mann–Whitney U test showed sig- zole—and venlafaxine. nificantly higher plasma concentrations of active moiety, as Methods A therapeutic drug monitoring database con- well as venlafaxine and O-desmethylvenlafaxine, in both PPI tained plasma concentrations of venlafaxine and its active groups [p = 0.023, p = 0.011, p = 0.026, ?29% active metabolite O-desmethylvenlafaxine. We considered three moiety, ?27% venlafaxine, ?36%

Journal

Clinical PharmacokineticsSpringer Journals

Published: Sep 2, 2017

References